Universal Informatics · Research reading room

Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial.

Bowen S, Witkiewitz K, Clifasefi SL, Grow J, Chawla N, Hsu SH, Carroll HA, Harrop E, Collins SE, Lustyk MK, Larimer ME. · JAMA psychiatry · 2014 · Randomized controlled trial

Original publication · Original publication · Original publication

Recorded summary

In 286 adults completing substance-use treatment, mindfulness-based relapse prevention reduced substance-use days and heavy drinking at 12 months relative to standard relapse prevention and usual aftercare.

Recorded limitations

Benefits varied by endpoint and time: standard relapse prevention delayed first drug use more effectively at six months. Results concern structured aftercare, not a stand-alone meditation cure for addiction.

Evidence and provenance

Chapter Trust Factor uses a minimum of three distinct qualifying studies. Publication records retain their own evidence and assessment.

Study design and assessment
design
Randomized controlled trial
assessment
category
peer-reviewed
peer Reviewed
true
basis
Reported design checked against the primary publication abstract. Blinding terminology reflects the source report, not an independent risk-of-bias rating.
sources

https://pubmed.ncbi.nlm.nih.gov/24647726/ · https://doi.org/10.1001/jamapsychiatry.2013.4546 · https://pmc.ncbi.nlm.nih.gov/articles/PMC4489711/

assessed At
2026-10-26
registered Masking Basis
false
trust Factor
score
2
scope
Paper
status
assessed
randomized Controlled Trial
true
blinding
not-confirmed
peer Reviewed
true
basis
Reported design checked against the primary publication abstract. Blinding terminology reflects the source report, not an independent risk-of-bias rating.
sources

https://pubmed.ncbi.nlm.nih.gov/24647726/ · https://doi.org/10.1001/jamapsychiatry.2013.4546 · https://pmc.ncbi.nlm.nih.gov/articles/PMC4489711/

review Scope
Existing publication-specific assessments and bibliographic indexing; no blanket full-text appraisal.
assessed At
2026-10-27
jadad
status
unassessed
score
Not recorded
evidence
intervention
Mindfulness-based relapse prevention
comparator
Relapse prevention and usual aftercare
evidence Type
Clinical or experimental outcomes
source URLs

https://pubmed.ncbi.nlm.nih.gov/24647726/ · https://doi.org/10.1001/jamapsychiatry.2013.4546 · https://pmc.ncbi.nlm.nih.gov/articles/PMC4489711/

checked At
2026-10-26
review Scope
Primary publication abstract and bibliographic identity checked; comprehensive full-text risk-of-bias and Jadad assessment pending.
discovery Sources

https://europepmc.org/article/MED/24647726

selection Policy
Success-focused discovery selection, with material limitations retained; not an exhaustive systematic review.
trial Id
NCT01159535
Topics and recorded topic scores
  1. key
    language:mindfulness-clinical
    title
    Mindfulness-based interventions: controlled clinical trials
    collection
    language
    trust Score
    2
Citation snapshot and identifiers
id
pmid-24647726
doi
10.1001/jamapsychiatry.2013.4546
pmid
24647726
citation Snapshot
count
384
source
Europe PMC
retrieved At
2026-10-26
url
https://europepmc.org/article/MED/24647726
citations By Collection
language
384
Complete approved library record
id
pmid-24647726
publication Key
doi:10.1001/jamapsychiatry.2013.4546
aliases
None recorded
title
Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial.
journal
JAMA psychiatry
neurotransmitters
None recorded
year
2014
authors
Bowen S, Witkiewitz K, Clifasefi SL, Grow J, Chawla N, Hsu SH, Carroll HA, Harrop E, Collins SE, Lustyk MK, Larimer ME.
design
Randomized controlled trial
identity Conflict
Not recorded
doi
10.1001/jamapsychiatry.2013.4546
pmid
24647726
urls

https://pubmed.ncbi.nlm.nih.gov/24647726/ · https://doi.org/10.1001/jamapsychiatry.2013.4546 · https://pmc.ncbi.nlm.nih.gov/articles/PMC4489711/

collections

language

categories

Clinical & self-report

targets
None recorded
priority
1
quotes
None recorded
summary
In 286 adults completing substance-use treatment, mindfulness-based relapse prevention reduced substance-use days and heavy drinking at 12 months relative to standard relapse prevention and usual aftercare.
limitation
Benefits varied by endpoint and time: standard relapse prevention delayed first drug use more effectively at six months. Results concern structured aftercare, not a stand-alone meditation cure for addiction.
citation Count
384
citation Snapshot
count
384
source
Europe PMC
retrieved At
2026-10-26
url
https://europepmc.org/article/MED/24647726
study Design Assessment
category
peer-reviewed
peer Reviewed
true
basis
Reported design checked against the primary publication abstract. Blinding terminology reflects the source report, not an independent risk-of-bias rating.
sources

https://pubmed.ncbi.nlm.nih.gov/24647726/ · https://doi.org/10.1001/jamapsychiatry.2013.4546 · https://pmc.ncbi.nlm.nih.gov/articles/PMC4489711/

assessed At
2026-10-26
registered Masking Basis
false
paper Trust Assessment
score
2
scope
Paper
status
assessed
randomized Controlled Trial
true
blinding
not-confirmed
peer Reviewed
true
basis
Reported design checked against the primary publication abstract. Blinding terminology reflects the source report, not an independent risk-of-bias rating.
sources

https://pubmed.ncbi.nlm.nih.gov/24647726/ · https://doi.org/10.1001/jamapsychiatry.2013.4546 · https://pmc.ncbi.nlm.nih.gov/articles/PMC4489711/

review Scope
Existing publication-specific assessments and bibliographic indexing; no blanket full-text appraisal.
assessed At
2026-10-27
citations By Collection
language
384
topics
  1. key
    language:mindfulness-clinical
    title
    Mindfulness-based interventions: controlled clinical trials
    collection
    language
    trust Score
    2
journal Key
jamapsychiatry
journal Label
JAMA psychiatry
chapter Entries
  1. title
    Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial.
    journal
    JAMA psychiatry
    year
    2014
    authors
    Bowen S, Witkiewitz K, Clifasefi SL, Grow J, Chawla N, Hsu SH, Carroll HA, Harrop E, Collins SE, Lustyk MK, Larimer ME.
    design
    Randomized controlled trial
    urls

    https://pubmed.ncbi.nlm.nih.gov/24647726/ · https://doi.org/10.1001/jamapsychiatry.2013.4546 · https://pmc.ncbi.nlm.nih.gov/articles/PMC4489711/

    doi
    10.1001/jamapsychiatry.2013.4546
    pmid
    24647726
    targets
    None recorded
    categories

    Clinical & self-report

    citation Count
    384
    citation Snapshot
    count
    384
    source
    Europe PMC
    retrieved At
    2026-10-26
    url
    https://europepmc.org/article/MED/24647726
    study Design Assessment
    category
    peer-reviewed
    peer Reviewed
    true
    basis
    Reported design checked against the primary publication abstract. Blinding terminology reflects the source report, not an independent risk-of-bias rating.
    sources

    https://pubmed.ncbi.nlm.nih.gov/24647726/ · https://doi.org/10.1001/jamapsychiatry.2013.4546 · https://pmc.ncbi.nlm.nih.gov/articles/PMC4489711/

    assessed At
    2026-10-26
    registered Masking Basis
    false
    evidence
    intervention
    Mindfulness-based relapse prevention
    comparator
    Relapse prevention and usual aftercare
    evidence Type
    Clinical or experimental outcomes
    source URLs

    https://pubmed.ncbi.nlm.nih.gov/24647726/ · https://doi.org/10.1001/jamapsychiatry.2013.4546 · https://pmc.ncbi.nlm.nih.gov/articles/PMC4489711/

    checked At
    2026-10-26
    review Scope
    Primary publication abstract and bibliographic identity checked; comprehensive full-text risk-of-bias and Jadad assessment pending.
    discovery Sources

    https://europepmc.org/article/MED/24647726

    selection Policy
    Success-focused discovery selection, with material limitations retained; not an exhaustive systematic review.
    trial Id
    NCT01159535
    id
    language-mindfulness-clinical-pmid-24647726
    record Id
    pmid-24647726
    quotes
    None recorded
    source Pages
    None recorded
    summary
    In 286 adults completing substance-use treatment, mindfulness-based relapse prevention reduced substance-use days and heavy drinking at 12 months relative to standard relapse prevention and usual aftercare.
    limitation
    Benefits varied by endpoint and time: standard relapse prevention delayed first drug use more effectively at six months. Results concern structured aftercare, not a stand-alone meditation cure for addiction.
    paper Trust Assessment
    score
    2
    scope
    Paper
    status
    assessed
    randomized Controlled Trial
    true
    blinding
    not-confirmed
    peer Reviewed
    true
    basis
    Reported design checked against the primary publication abstract. Blinding terminology reflects the source report, not an independent risk-of-bias rating.
    sources

    https://pubmed.ncbi.nlm.nih.gov/24647726/ · https://doi.org/10.1001/jamapsychiatry.2013.4546 · https://pmc.ncbi.nlm.nih.gov/articles/PMC4489711/

    review Scope
    Existing publication-specific assessments and bibliographic indexing; no blanket full-text appraisal.
    assessed At
    2026-10-27
    publication Key
    doi:10.1001/jamapsychiatry.2013.4546
    collection
    language
    chapter Number
    4
    topic Id
    mindfulness-clinical
    topic Title
    Mindfulness-based interventions: controlled clinical trials
    trust Score
    2
evidence
intervention
Mindfulness-based relapse prevention
comparator
Relapse prevention and usual aftercare
evidence Type
Clinical or experimental outcomes
source URLs

https://pubmed.ncbi.nlm.nih.gov/24647726/ · https://doi.org/10.1001/jamapsychiatry.2013.4546 · https://pmc.ncbi.nlm.nih.gov/articles/PMC4489711/

checked At
2026-10-26
review Scope
Primary publication abstract and bibliographic identity checked; comprehensive full-text risk-of-bias and Jadad assessment pending.
discovery Sources

https://europepmc.org/article/MED/24647726

selection Policy
Success-focused discovery selection, with material limitations retained; not an exhaustive systematic review.
trial Id
NCT01159535
jadad
status
unassessed
score
Not recorded
condition Evidence
  1. id
    substance-use
    evidence
    1. field
      curated primary-source summary
      text
      In 286 adults completing substance-use treatment, mindfulness-based relapse prevention reduced substance-use days and heavy drinking at 12 months relative to standard relapse prevention and usual aftercare.
      matched Text
      substance-use
conditions

substance-use

topic Trust Scores

2

full Text
status
not-indexed
retrieval Available
false

Open this publication in the interactive library